Showing results for "BIOS" in Science

Naming Darwin's Black Box to the National Review's list of the 100 most important nonfiction works of the 20th century, George Gilder wrote that it "overthrows Darwin at the end of the 20th century in the same way that quantum theory overthrew Newton at the beginning". Discussing the book in the New Yorker in May 2005, H. Allen Orr said of Behe, "He is the most prominent of the small circle of scientists working on intelligent design, and his arguments are by far the best known."

Dr. Riley Kirk is a cannabis research scientist and educator. She obtained her Ph.D. in pharmaceutical sciences, specializing in natural product chemistry, studying the traditional and contemporary uses of hundreds of medicinal plants. She is currently an assistant associate professor at the University of Rhode Island, has worked as an immunology scientist in the biotech industry, and works in the cannabis industry studying the chemical complexity of cannabis smoke. Riley is also the co-founder of the cannabis research and education non-profit organization called the Network of Applied ...

The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. Biotech will mean that we can live far better, safer, healthier, wealthier, happier, and longer lives.

This is the podcast for animal and plant lovers especially people who love the unusual and creepy crawlies of the world we talk about care for these plants and animals as well as all different types of things involving these living organisms in our homes

This Very Short Introduction discusses the key concepts of biochemistry, as well as the historical figures in the field and the molecules they studied, before considering the current science and innovations in the field, and the interaction between biochemistry, biotechnology, and synthetic biology.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

Written by experts and authorities in the field and professionally narrated for easy listening, this crash course is a valuable tool both during school and when preparing for the USMLE, or if you're simply interested in the subject of human Biochemistry. The audio is focused and high-yield, covering the most important topics you might expect to learn in a typical Medical school Biochemistry course. Included are both capsule and detailed explanations of critical issues and topics you must know to master Medical School-level Biochemistry. The material is accurate, up to date and broken down into bite-sized sections. There is a "Q&A" and a "key takeaways" section following each topic to review questions commonly tested and drive home key points.

The Go-to Podcast for Biotech Scientists Who Want to Master Bioprocess CMC Development and Manufacturing of Biologics.**TOP 10 LIFE SCIENCES PODCAST**Do you want to simplify bioprocessing so that you can scale with confidence and reduce time to market?Are you sick of feeling overwhelmed by the complexity and guesswork of biologics drug development?Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?There’s a way to simplify and streamline so you can remove complexity, skip trials and errors, ...

In this audiobook, you will be given an overview of the field of biochemistry. The following sections will take you through the fundamentals of biochemistry, starting with a short background in the field, an overview of the types of cells that are studied by biochemists, and the organization of structures within those cells. This will be followed by an introduction to the types of molecules that biochemists take interest in - proteins, nucleic acids, carbohydrates, and lipids.

Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our hosts delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, science, drug discovery, and in the cure and treatment of diseases. Music from NOWHERE by ikson™ (https://...

In Fit for a Purpose, biochemist Fazale Rana fearlessly pushes the boundaries of the anthropic principle beyond cosmology. In the process, Rana invites the listener to discover the world of chemical and biochemical fine-tuning, as well as to contemplate this question: If the universe is fit for life, and biochemical systems are fit for their role in life, is it possible that everything is “fit for a purpose”?

In Frankenstein's Cat, journalist Emily Anthes takes us from petri dish to pet store as she explores how biotechnology is shaping the future of our furry and feathered friends. Through her encounters with scientists, conservationists, ethicists, and entrepreneurs, Anthes reveals that while some of our interventions may be trivial (behold: the GloFish), others could improve the lives of many species - including our own. So what does biotechnology really mean for the world's wild things? And what do our brave new beasts tell us about ourselves?

Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.

While education and experience are critical for the working scientist, there is another factor that makes all the difference in the lab: happy people are more productive. Yours is a serious mission, but that doesn’t mean you shouldn’t enjoy carrying out that mission. Your well being impacts both your work and your career. Each episode of The Happy Scientist dials in on hands on, actionable steps you can take to make sure you stay happy, focused and satisfied in the lab. Join us to experience a more fulfilling career in bioscience.

The Apples, Amazons and Googles of the next few decades will be biotech companies. The tech companies of the last few years have changed how we do things but the businesses driving the biotech revolution are about making life better. These companies will solve many of our most intractable problems: cancer, dementia, diabetes, elderly care, mental health challenges, even power generation and agricultural production. The audiobook explains what biotech is, what is coming next, and in a final section, how interested investors can profit from it.

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry.Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends allow Steve to add valued insight to every conversation. Whether salary levels, technology trends or ...

"We Are Biochemistry: The Science That Connects Us" explores life's molecular world. This 3000-level equivalent podcast covers key topics: biomolecules, metabolism, genetic engineering, and more. Join experts for engaging discussions and real-world applications. Perfect for students, professionals, and curious minds alike! Disclaimer: AI-generated content (GoogleLM) for educational use only. Not a sole study resource or substitute for professional advice. Content may contain errors; verify independently. Field evolves rapidly; info may become outdated. No medical advice intended.

Come si diventa contadini ad un passo dalla data di scadenza - Ogni lunedì alle 18.00 ti racconteremo la vita di campagna e come crescono i prodotti della nostra terra.Vogliamo riportare la tavola a essere occasione di condivisione e incontro. Insieme a Barbara viviamo su una collina nel Monferrato in una casa nel bosco, io sono Gian Luigi.Se vuoi fare parte del nostro gruppo WhatsApp clicca qui.

In het bijbelse boek Prediker was de vraag retorisch: “Wie kan recht maken wat God krom heeft gemaakt?” In onze tijd begint het er sterk op te lijken dat de mens hiertoe wel degelijk in staat is. Sinds de ontrafeling van de structuur van DNA in 1953 is de kennis van het erfelijke materiaal van levende organismen spectaculair toegenomen. Wat in de 19e en vroeg 20e eeuw begon met erwten en fruitvliegjes, resulteerde in het begin van de 21e eeuw in de ontrafeling van het menselijke genoom.